{"public_id":"cl_7840e9894ac730c62b93d44a287e46d9","status":"active","superseded_by_public_id":null,"corpus_id":251478343,"text":"Intravitreal brolucizumab is expected to reduce treatment burden in neovascular age-related macular degeneration by achieving comparable therapeutic outcomes with fewer clinic visits.","confidence":0.9,"paper":{"corpus_id":251478343,"title":"Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies","url":"https://sah.borca.ai/papers/251478343"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_019ee9ac763b9a9e8e46b02b2fd81c71","name":"treatment burden","description":"The amount of clinical monitoring, injections, and visits required to manage a chronic eye disease.","types":["outcome","care burden"],"url":"https://sah.borca.ai/concepts/co_019ee9ac763b9a9e8e46b02b2fd81c71"},{"public_id":"co_3a921bd382d872430f8e2a84eca0d7e8","name":"intravitreal brolucizumab","description":"Administration of brolucizumab directly into the eye's vitreous cavity.","types":["administration route","treatment"],"url":"https://sah.borca.ai/concepts/co_3a921bd382d872430f8e2a84eca0d7e8"},{"public_id":"co_7214aea89ae8736cc8c60353bbca8b4b","name":"neovascular age-related macular degeneration","description":"A form of age-related macular degeneration characterized by choroidal neovascularization and severe vision loss.","types":["disease"],"url":"https://sah.borca.ai/concepts/co_7214aea89ae8736cc8c60353bbca8b4b"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_7840e9894ac730c62b93d44a287e46d9"}